KALA logo

KALA BIO, Inc. (KALA)

Profile

Full Name

KALA BIO, Inc.

Ticker

NASDAQ: KALA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 20, 2017

Indexes

Not included

Website

https://www.kalarx.com

Employees

38

Key Details

Price

$0.95(-27.48%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$10.14(41.53% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.95
    KALA price is $0.95

    30-Day Relative Volume

    2.17
    KALA 30-day relative volume is 2.17

    Price Performance

    Price Most Recent Change

    -27.48%
    KALA price was down -27.48% on Oct 20, 2025

    Price YTD Change

    -86.31%
    KALA price is down -86.31% since January 1st

    Price 1-Year Change

    -81.87%
    KALA price is down -81.87% year-on-year

    Price 3-Year Change

    -88.12%
    KALA price is down -88.12% over the past 3 years

    Price Range

    Price All-Time High

    $1337.50
    KALA price is currently -99.93% below its historical high of $1337.50

    Price 3-Year Low

    $0.80
    KALA price is currently +18.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $6.67M
    KALA market cap is $6.67 million

    Market Cap 3-Year Change

    -43.06%
    KALA market cap is down -43.06% over the past 3 years

    Market Cap All-Time High

    $768.31M
    KALA market cap is currently -99.13% below its historical high of $768.31 million

    Market Cap Sector Percentile

    10.79%
    KALA market cap is higher than 10.79% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +52.3%
    KALA shares outstanding is up +52.3% year-on-year

    Shares Outstanding 3-Year Change

    +375.48%
    KALA shares outstanding is up +375.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.07
    KALA beta is 1.07

    200-day SMA

    $6.76
    KALA price is currently -85.94% below its 200-day simple moving average

    50-day SMA

    $9.50
    KALA price is currently -90.00% below its 50-day simple moving average

    14-Day RSI

    26.61
    KALA 14-day relative strength index is 26.61

    Volume

    2.17
    KALA 30-day relative volume is 2.17

    ATR

    $1.07
    KALA average true range is $1.07

    10-day Historical Volatility

    151.65%
    KALA 10-day historical volatility is 151.65%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KALA annual revenue is $0.00

    Revenue Analysts Estimate

    -
    KALA annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    KALA annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.79%
    KALA annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$10.14
    KALA annual earnings per share is -$10.14

    EPS Analysts Estimate

    -$5.40
    KALA annual earnings per share is currently -87.96% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +41.53%
    KALA annual earnings per share is up +41.53% year-on-year

    EPS Sector Percentile

    14.18%
    KALA annual earnings per share is higher than 14.18% of companies in Healthcare sector

    Profit

    Gross Profit

    -$259.00K
    KALA annual gross profit is -$259.00 thousand

    Gross Margin

    -
    KALA annual gross profit margin value is unknown

    Operating Profit

    -$40.43M
    KALA annual operating income is -$40.43 million

    Operating Margin

    -
    KALA annual operating profit margin value is unknown

    Net Income

    -$38.51M
    KALA annual net profit is -$38.51 million

    Net Margin

    -
    KALA annual net profit margin value is unknown

    Expenses

    Total Expenses

    $38.51M
    KALA annual total expenses is $38.51 million

    Operating Expenses

    $40.17M
    KALA annual total operating expenses is $40.17 million

    Cost Of Goods Sold

    $259.00K
    KALA annual cost of goods sold is $259.00 thousand

    Selling, General & Administrative Expenses

    $0.00
    KALA annual SG&A is $0.00

    Depreciation & Amortization

    $259.00K
    KALA annual D&A is $259.00 thousand

    Interest Expense

    $0.00
    KALA annual interest expense is $0.00

    Income Tax

    $0.00
    KALA annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$40.43M
    KALA annual earnings before interest & taxes is -$40.43 million

    EBITDA

    -$40.17M
    KALA annual EBITDA is -$40.17 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $55.48M
    KALA annual total assets is $55.48 million

    Non Current Assets

    $2.69M
    KALA annual long term assets is $2.69 million

    Current Assets

    $52.80M
    KALA annual total current assets is $52.80 million

    Cash and Cash Equivalents

    $51.18M
    KALA annual cash & cash equivalents is $51.18 million

    Accounts Receivable

    -
    KALA annual accounts receivable value is unknown

    Inventory

    $0.00
    KALA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $43.15M
    KALA annual total liabilities is $43.15 million

    Long Term Liabilities

    $26.20M
    KALA annual total long term liabilities is $26.20 million

    Current Liabilities

    $16.96M
    KALA annual current liabilities is $16.96 million

    Accounts Payable

    $628.00K
    KALA annual accounts payable is $628.00 thousand

    Debt

    Total Debt

    $32.25M
    KALA annual total debt is $32.25 million

    Total Debt 1-Year Change

    -11.21%
    KALA annual total debt is down -11.21% year-on-year

    Long Term Debt

    $21.54M
    KALA annual long term debt is $21.54 million

    Short Term Debt

    $10.72M
    KALA annual short term debt is $10.72 million

    Equity & Capital

    Shareholders Equity

    $12.33M
    KALA annual stockholders equity is $12.33 million

    Book Value

    $12.33M
    KALA annual book value is $12.33 million

    Retained Earnings

    -$667.92M
    KALA annual retained earnings is -$667.92 million

    Working Capital

    $35.84M
    KALA annual working capital is $35.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$29.38M
    KALA annual cash from operations is -$29.38 million

    Cash From Operations 1-Year Change

    -5.21%
    KALA annual cash from operations is down -5.21% year-on-year

    Cash From Investing

    -$208.00K
    KALA annual cash from investing is -$208.00 thousand

    Cash From Investing 1-Year Change

    +51.52%
    KALA annual cash from investing is up +51.52% year-on-year

    Cash From Financing

    $29.88M
    KALA annual cash from financing is $29.88 million

    Cash From Financing 1-Year Change

    +251.23%
    KALA annual cash from financing is up +251.23% year-on-year

    CAPEX

    CAPEX

    $208.00K
    KALA annual capital expenditures is $208.00 thousand

    CAPEX 1-Year Change

    -65.9%
    KALA annual capital expenditures is down -65.9% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$29.59M
    KALA annual free cash flow is -$29.59 million

    Free Cash Flow 1-Year Change

    -3.69%
    KALA annual free cash flow is down -3.69% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    KALA annual gross profit margin value is unknown

    Operating Margin

    -
    KALA annual operating profit margin value is unknown

    Net Margin

    -
    KALA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -69.12%
    KALA annual return on assets is -69.12%

    ROE

    -388.29%
    KALA annual return on equity is -388.29%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    KALA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    KALA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -2.08
    KALA price to book ratio is -2.08

    PB Ratio Sector Percentile

    9.42%
    KALA price to book ratio is higher than 9.42% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    KALA price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    KALA price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $4.66M
    KALA enterprise value is $4.66 million

    Enterprise Value Sector Percentile

    15.21%
    KALA enterprise value is higher than 15.21% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.12
    KALA EV/EBITDA is -0.12

    EV/EBITDA Sector Percentile

    63.72%
    KALA EV/EBITDA is higher than 63.72% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.11
    KALA annual current ratio is 3.11

    Quick Ratio

    3.11
    KALA annual quick ratio is 3.11

    Leverage

    Debt To Equity

    2.62
    KALA annual debt to equity ratio is 2.62

    Interest Coverage Ratio

    -
    KALA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    KALA piotroski f-score value is unknown

    Altman Z-Score

    -18.39
    KALA altman z-score is -18.39

    Analyst ratings

    Recent major analysts updates

    Sep 29, 25 HC Wainwright & Co.
    Neutral
    Sep 17, 25 HC Wainwright & Co.
    Buy
    Sep 11, 25 Oppenheimer
    Outperform
    Sep 8, 25 Mizuho
    Outperform
    May 23, 25 HC Wainwright & Co.
    Buy
    Apr 4, 25 HC Wainwright & Co.
    Buy
    Feb 13, 25 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Aug 19, 24 Oppenheimer
    Outperform
    May 17, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with KALA included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for KALA BIO, Inc.?
    • Does KALA BIO, Inc. pay dividends?
    • What sector is KALA BIO, Inc. in?
    • What industry is KALA BIO, Inc. in?
    • What country is KALA BIO, Inc. based in?
    • When did KALA BIO, Inc. go public?
    • Is KALA BIO, Inc. in the S&P 500?
    • Is KALA BIO, Inc. in the NASDAQ 100?
    • Is KALA BIO, Inc. in the Dow Jones?
    • When was KALA BIO, Inc.'s last earnings report?
    • When does KALA BIO, Inc. report earnings?

    What is the ticker symbol for KALA BIO, Inc.?

    The ticker symbol for KALA BIO, Inc. is NASDAQ:KALA

    Does KALA BIO, Inc. pay dividends?

    No, KALA BIO, Inc. does not pay dividends

    What sector is KALA BIO, Inc. in?

    KALA BIO, Inc. is in the Healthcare sector

    What industry is KALA BIO, Inc. in?

    KALA BIO, Inc. is in the Biotechnology industry

    What country is KALA BIO, Inc. based in?

    KALA BIO, Inc. is headquartered in United States

    When did KALA BIO, Inc. go public?

    KALA BIO, Inc.'s initial public offering (IPO) was on July 20, 2017

    Is KALA BIO, Inc. in the S&P 500?

    No, KALA BIO, Inc. is not included in the S&P 500 index

    Is KALA BIO, Inc. in the NASDAQ 100?

    No, KALA BIO, Inc. is not included in the NASDAQ 100 index

    Is KALA BIO, Inc. in the Dow Jones?

    No, KALA BIO, Inc. is not included in the Dow Jones index

    When was KALA BIO, Inc.'s last earnings report?

    KALA BIO, Inc.'s most recent earnings report was on May 13, 2025

    When does KALA BIO, Inc. report earnings?

    The date for KALA BIO, Inc.'s next earnings report has not been announced yet
    On this page